Restart Life Sciences Corp. (HEAL.CX)
0.065
-0.02
(-18.75%)
CAD |
CNSX |
Nov 13, 16:00
Restart Life Sciences Price : 0.065 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 0.075 | 0.075 | 0.065 | 0.065 | 49002.00 |
| Nov 12, 2026 | 0.065 | 0.08 | 0.065 | 0.08 | 120028.0 |
| Nov 11, 2026 | 0.07 | 0.08 | 0.07 | 0.075 | 42000.00 |
| Nov 10, 2026 | 0.07 | 0.07 | 0.07 | 0.07 | 50000.00 |
| Nov 09, 2026 | 0.075 | 0.075 | 0.065 | 0.065 | 170478.0 |
| Nov 06, 2026 | 0.085 | 0.085 | 0.065 | 0.08 | 301805.0 |
| Nov 05, 2026 | 0.08 | 0.08 | 0.08 | 0.08 | 0.000 |
| Nov 04, 2026 | 0.07 | 0.07 | 0.07 | 0.07 | 277456.0 |
| Nov 03, 2026 | 0.08 | 0.085 | 0.08 | 0.085 | 33000.00 |
| Nov 02, 2026 | 0.07 | 0.07 | 0.07 | 0.07 | 0.000 |
| Oct 30, 2026 | 0.08 | 0.08 | 0.08 | 0.08 | 1000.00 |
| Oct 29, 2026 | 0.07 | 0.07 | 0.065 | 0.065 | 190750.0 |
| Oct 28, 2026 | 0.07 | 0.07 | 0.07 | 0.07 | 201000.0 |
| Oct 27, 2026 | 0.07 | 0.07 | 0.07 | 0.07 | 0.000 |
| Oct 26, 2026 | 0.075 | 0.075 | 0.075 | 0.075 | 0.000 |
| Oct 23, 2026 | 0.07 | 0.07 | 0.07 | 0.07 | 0.000 |
| Oct 22, 2026 | 0.075 | 0.075 | 0.075 | 0.075 | 52667.00 |
| Oct 21, 2026 | 0.07 | 0.07 | 0.07 | 0.07 | 0.000 |
| Oct 20, 2026 | 0.07 | 0.07 | 0.07 | 0.07 | 1279.00 |
| Oct 19, 2026 | 0.07 | 0.07 | 0.07 | 0.07 | 0.000 |
| Oct 16, 2026 | 0.07 | 0.07 | 0.07 | 0.07 | 0.000 |
| Oct 15, 2026 | 0.07 | 0.07 | 0.07 | 0.07 | 0.000 |
| Oct 14, 2026 | 0.07 | 0.07 | 0.07 | 0.07 | 5800.00 |
| Oct 13, 2026 | 0.075 | 0.075 | 0.07 | 0.07 | 29750.00 |
| Oct 09, 2026 | 0.08 | 0.08 | 0.08 | 0.08 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Spectral Medical, Inc. | 1.00 |
| Resverlogix Corp. | 0.075 |
| Theratechnologies, Inc. | 4.47 |
| COSCIENS Biopharma, Inc. | 8.32 |
| Defence Therapeutics Inc | 0.29 |
Price Related Metrics
| PS Ratio | 7.191 |
| PEG Ratio | -0.0463 |
| Price to Book Value | 3.060 |
| Earnings Yield | -48.31% |
| Market Cap | 4.053M |
| PEGY Ratio | -0.0463 |